US Broker Ratings

Mesoblast Limited (MESO) Stock Analysis: Unpacking the 109% Upside Potential and Latest Developments

Mesoblast Limited (MESO), a prominent player in the biotechnology sector, is capturing investor attention with its impressive potential upside of 109.83%. With a market capitalization of $2.16 billion, this Australian-based..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Potential 91% Upside Awaits Investors

Beam Therapeutics Inc. (NASDAQ: BEAM), a prominent player in the biotechnology sector, captivates investor interest with its innovative approach to precision genetic medicines. Based in Cambridge, Massachusetts, Beam Therapeutics is..

LivaNova PLC (LIVN) Stock Analysis: Healthcare Innovator with 16.89% Upside Potential

LivaNova PLC (NASDAQ: LIVN), a leading player in the medical devices sector, offers a compelling investment opportunity within the healthcare industry. Headquartered in the United Kingdom, LivaNova specializes in the..

Structure Therapeutics Inc. (GPCR): Investor Outlook with Nearly 95% Potential Upside

Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage biopharmaceutical company, is capturing the attention of investors with its promising pipeline and substantial potential upside. Operating at the intersection of healthcare and..

Certara, Inc. (CERT) Stock Analysis: Navigating Growth in Health Information Services

Certara, Inc. (CERT), a prominent player in the health information services sector, offers investors a unique proposition with its technology-driven services and software products for biosimulation in drug discovery. Headquartered..

AtriCure, Inc. (ATRC) Stock Analysis: Exploring a 13.67% Potential Upside in the Medical Devices Sector

AtriCure, Inc. (NASDAQ: ATRC) is positioning itself as a noteworthy player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $2.12 billion,..

Evotec SE (EVO) Stock Analysis: Exploring an 84% Potential Upside for Strategic Investors

In the dynamic and highly competitive healthcare sector, Evotec SE (EVO) stands out as a significant player in the drug manufacturing industry, focusing on specialty and generic drugs. With its..

CONMED Corporation (CNMD)

⚠️ No article content returned.

..

DENTSPLY SIRONA (XRAY): Navigating Challenges with a 17.66% Potential Upside

For investors keeping an eye on the healthcare sector, DENTSPLY SIRONA Inc. (NASDAQ: XRAY) presents an intriguing proposition. This leading manufacturer in the medical instruments and supplies industry, headquartered in..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Exploring a 63.62% Upside with Cutting-Edge Gene Editing Technologies

CRISPR Therapeutics AG (NASDAQ: CRSP) stands at the forefront of the biotechnology sector with its revolutionary gene-editing technologies. Headquartered in Zug, Switzerland, this pioneering company leverages the CRISPR/Cas9 platform to..

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Potential Upside of Over 120% Sparks Investor Interest

Recursion Pharmaceuticals, Inc. (RXRX), a pioneering entity in the biotechnology sector, has captured investor attention with the potential for a remarkable 120.36% upside, according to analyst ratings. This clinical-stage biotech..

Bausch Health Companies Inc. (BHC) Stock Analysis: Exploring an 18% Upside Amidst Strong Revenue Growth

Bausch Health Companies Inc. (NYSE: BHC) is commanding attention in the healthcare sector with an intriguing blend of growth and potential upside. With its roots firmly planted in the drug..

Centessa Pharmaceuticals plc (CNTA) Investor Outlook: Navigating Biotech Potential Amidst Market Stability

For investors interested in the dynamic world of biotechnology, Centessa Pharmaceuticals plc (NASDAQ: CNTA) presents a unique opportunity. With a market capitalization of $6.27 billion, Centessa is a player to..

SS Innovations International (SSII) Stock Analysis: Unpacking the 86.67% Potential Upside

SS Innovations International Inc. (SSII), a prominent player in the healthcare sector, is making waves in the medical devices industry with its innovative approach to surgical robotics. Headquartered in Gurugram,..

PROCEPT BioRobotics (PRCT) Stock Analysis: Navigating Growth in the Medical Device Sector

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is a notable player in the healthcare sector, specifically within the medical devices industry, with a focus on surgical robotics. Headquartered in San Jose, California,..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: A 42% Upside Potential in the Biotechnology Sector

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), a burgeoning player in the healthcare sector, is capturing the attention of investors with its promising potential upside of 42.26%. This biopharmaceutical company, headquartered in..

BioCryst Pharmaceuticals, Inc. (BCRX) Investor Outlook: Exploring a 111.57% Potential Upside

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) stands out in the biopharmaceutical sector with an exciting growth narrative, driven by its innovative approach to treating rare diseases. With a market capitalization of..

Ascentage Pharma Group Internat (AAPG) Stock Analysis: Exploring a 152% Potential Upside in Biotech Innovations

Ascentage Pharma Group International (AAPG), a dynamic player in the biotechnology sector, is capturing investor attention with its impressive potential upside of 152.15%. Headquartered in Suzhou, China, Ascentage Pharma is..

QuidelOrtho Corporation (QDEL): Investor Outlook on Growth Amidst Challenges and Opportunities

QuidelOrtho Corporation (NASDAQ: QDEL), a notable player in the healthcare sector’s medical devices industry, presents a mixed bag of opportunities and challenges for investors. With a market capitalization of $942.91..

Kiniksa Pharmaceuticals (KNSA) Stock Analysis: A Promising Outlook with 28% Potential Upside

Kiniksa Pharmaceuticals International (NASDAQ: KNSA) is making waves in the healthcare sector, particularly within the specialized field of drug manufacturing. With a focus on developing innovative therapies for complex medical..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds